|
Market Closed -
Nasdaq
01:30:00 21/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 514.65 USD | +2.53% |
|
+6.07% | +13.52% |
| 15/10 | Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $654 From $653 | MT |
| 09/10 | Vertex Pharmaceuticals Says Alyftrek Delivers Pancreatic Function Recovery in Some Children | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.53% | +6.07% | +1.24% | +7.11% | +13.52% | +22.80% | +42.22% | +177.45% | +520.66% | 13TCr | |
| +3.49% | +10.04% | +11.34% | +11.92% | +19.45% | +58.68% | +119.56% | +426.69% | +1,530.25% | 1,14400Cr | |
| +2.19% | +4.32% | -3.94% | +4.24% | +25.32% | +33.88% | +69.52% | +58.36% | +125.79% | 63TCr | |
| +2.26% | +5.37% | +9.52% | +14.09% | +26.52% | +24.57% | +97.69% | +166.65% | +368.07% | 51TCr | |
| -0.53% | +8.37% | +9.28% | +17.55% | +18.80% | +38.71% | +63.14% | +10.70% | +67.70% | 38TCr | |
| +3.25% | +4.45% | +0.97% | +19.21% | +40.89% | +71.80% | +44.44% | +82.93% | +139.50% | 37TCr | |
| -0.28% | +6.04% | +9.90% | +2.76% | +15.42% | +21.47% | +49.17% | +62.76% | +68.22% | 29TCr | |
| -0.21% | +6.07% | +0.94% | +1.92% | -8.50% | +0.43% | +20.98% | +43.91% | +153.50% | 26TCr | |
| +3.29% | +6.32% | +13.82% | +20.53% | +34.11% | +44.71% | +57.43% | +109.36% | +171.79% | 24TCr | |
| +2.25% | +5.81% | +4.26% | +17.49% | +27.51% | +27.13% | +101.17% | +134.09% | +110.62% | 19TCr | |
| -0.65% | +2.42% | +0.83% | -19.10% | -19.40% | -26.14% | -61.57% | -21.50% | +84.87% | 17TCr | |
| +2.28% | +6.13% | +8.86% | +21.66% | +20.92% | +21.95% | -1.76% | -29.65% | -7.47% | 17TCr | |
| +4.84% | +8.84% | -2.19% | +2.53% | +14.35% | +41.50% | +9.25% | +6.22% | +22.48% | 13TCr | |
| +1.95% | +7.09% | +17.78% | +23.89% | +25.58% | +30.76% | +127.49% | +399.84% | +536.07% | 12TCr | |
| -0.28% | +6.59% | -0.48% | -0.72% | +2.41% | +14.39% | +27.80% | +6.15% | -10.25% | 10TCr | |
| -0.18% | +2.23% | -1.57% | -4.34% | -11.24% | -14.91% | -25.32% | -12.54% | +6.10% | 9.9TCr | |
| +6.69% | +11.94% | +57.15% | +306.93% | +720.89% | +788.69% | +201.09% | -27.31% | - | 9.66TCr | |
| +3.25% | +7.22% | +2.88% | +20.13% | +4.61% | +40.00% | -0.12% | +43.50% | +117.51% | 8.06TCr | |
| -0.36% | +6.40% | +12.75% | +8.48% | +19.41% | +29.61% | -1.61% | -26.08% | +47.51% | 7.15TCr | |
| +1.26% | +7.80% | -2.09% | -11.98% | -21.01% | -9.04% | +44.08% | +67.94% | +449.45% | 6.69TCr | |
| Average | +1.01% | +5.36% | +7.56% | +23.22% | +48.48% | +63.05% | +49.23% | +83.97% | +236.97% | 26.22TCr | |
| Weighted average by Cap. | +0.82% | +4.99% | +6.96% | +15.60% | +31.54% | +48.82% | +68.04% | +151.02% | +467.67% |
- Stock Market
- Stocks
- VRTX Stock
- Sector Vertex Pharmaceuticals Incorporated
Select your edition
All financial news and data tailored to specific country editions
